Cargando…

Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer

SIMPLE SUMMARY: Endocrine therapy is a common treatment for estrogen-responsive breast cancer, which is used to block the tumor growth-promoting effect of this hormone. The resistance of breast cancer patients to endocrine therapy is a major clinical problem which could be solved by a deeper underst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treeck, Oliver, Haerteis, Silke, Ortmann, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046587/ https://www.ncbi.nlm.nih.gov/pubmed/36980520 http://dx.doi.org/10.3390/cancers15061632

Ejemplares similares

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy
por: Treeck, Oliver
Publicado: (2023)

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2023)

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling
por: Weber, Florian, et al.
Publicado: (2023)

Expression of estrogen-related receptors in ovarian cancer and impact on survival
por: Schüler-Toprak, Susanne, et al.
Publicado: (2021)

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
por: Schüler-Toprak, Susanne, et al.
Publicado: (2016)

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2018)

Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells
por: Treeck, Oliver, et al.
Publicado: (2019)

Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile
por: Treeck, Oliver, et al.
Publicado: (2022)

Non-canonical Estrogen Signaling in Endocrine Resistance
por: Ranganathan, Prathibha, et al.
Publicado: (2019)

Chemerin and Cancer
por: Treeck, Oliver, et al.
Publicado: (2019)

The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis
por: Schüler-Toprak, Susanne, et al.
Publicado: (2022)

Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
por: Horie, Kuniko, et al.
Publicado: (2022)

Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry
por: Inwald, E. C., et al.
Publicado: (2015)

Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
por: Sedano, Melina J., et al.
Publicado: (2020)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
por: Xu, Jing, et al.
Publicado: (2023)

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
por: Howard, Erin W., et al.
Publicado: (2018)

Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells
por: Karakas, Bahriye, et al.
Publicado: (2021)

Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer
por: Schüler, Susanne, et al.
Publicado: (2014)

Perspectives on the Role of Non-Coding RNAs in the Regulation of Expression and Function of the Estrogen Receptor
por: Taheri, Mohammad, et al.
Publicado: (2020)

Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response
por: Schmitt, Meike, et al.
Publicado: (2022)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
por: Liu, Shuying, et al.
Publicado: (2014)

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022)

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
por: Klinge, Carolyn M.
Publicado: (2015)

Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
por: González-Mora, Andrea Magali, et al.
Publicado: (2021)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

The long and short non-coding RNAs modulating EZH2 signaling in cancer
por: Mirzaei, Sepideh, et al.
Publicado: (2022)

Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy
por: Malagrinò, Matteo, et al.
Publicado: (2023)

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

RF13 | PMON142 Long Non-coding RNAs in Pituitary Differentiation and Endocrine Function
por: Camper, Sally, et al.
Publicado: (2022)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020)

Breast Cancer and the Other Non-Coding RNAs
por: Dvorská, Dana, et al.
Publicado: (2021)

Editorial: Non-Coding RNAs in Breast Cancer
por: Zhang, Wenwen, et al.
Publicado: (2021)

Overview of non-coding RNAs in breast cancers
por: Dabi, Yohann, et al.
Publicado: (2022)

Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management
por: Melone, Viola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llqc4vr3vp1ccdqdlbl9pbll7p